Literature DB >> 25239987

Streptococcus pneumoniae bacteraemia leading to the diagnosis of multiple myeloma.

Savita Shahani1, Lokesh Shahani2.   

Abstract

Multiple myeloma (MM) is a malignant plasma cell disorder characterised by the neoplastic proliferation of a single clone of plasma cells producing a monoclonal immunoglobulin. Anaemia, bone pain from lytic lesions, hypercalcaemia and renal failure are the most common presentations at diagnosis; however, the presence of infection at the time of diagnosis is rarely reported. The author reports an elderly male presenting with isolated fever and initial blood cultures positive for Streptococcus pneumoniae. Investigating the patient's underlying immunodeficient state predisposing him to this infection, serum and urine immunofixation electrophoresis identified monoclonal IgG λ and bone marrow biopsy revealed diffuse plasma cell infiltration that comprised 35% of the cellular elements, which were all consistent with MM. This case report highlights the importance of considering MM in asymptomatic elderly patients who present with acute pneumococcal infection without an apparent predisposing factor. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25239987      PMCID: PMC4170236          DOI: 10.1136/bcr-2014-204472

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

1.  Clinical features of patients with recurrent invasive Streptococcus pneumoniae disease.

Authors:  Maurice A Mufson; Jenelle B Hao; Ronald J Stanek; Nancy B Norton
Journal:  Am J Med Sci       Date:  2012-04       Impact factor: 2.378

2.  Increased risk of invasive pneumococcal disease in haematological and solid-organ malignancies.

Authors:  A Wong; T J Marrie; S Garg; J D Kellner; G J Tyrrell
Journal:  Epidemiol Infect       Date:  2010-04-30       Impact factor: 2.451

3.  Impaired synthesis of polyclonal (non-paraprotein) immunoglobulins by circulating lymphocytes from patients with multiple myeloma Role of suppressor cells.

Authors:  S Broder; R Humphrey; M Durm; M Blackman; B Meade; C Goldman; W Strober; T Waldmann
Journal:  N Engl J Med       Date:  1975-10-30       Impact factor: 91.245

4.  Defective binding of the third component of complement (C3) to Streptococcus pneumoniae in multiple myeloma.

Authors:  B D Cheson; H S Walker; M E Heath; R J Gobel; J Janatova
Journal:  Blood       Date:  1984-04       Impact factor: 22.113

5.  Cancer statistics, 2013.

Authors:  Rebecca Siegel; Deepa Naishadham; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2013-01-17       Impact factor: 508.702

6.  2013 IDSA clinical practice guideline for vaccination of the immunocompromised host.

Authors:  Lorry G Rubin; Myron J Levin; Per Ljungman; E Graham Davies; Robin Avery; Marcie Tomblyn; Athos Bousvaros; Shireesha Dhanireddy; Lillian Sung; Harry Keyserling; Insoo Kang
Journal:  Clin Infect Dis       Date:  2014-02       Impact factor: 9.079

7.  Review of 1027 patients with newly diagnosed multiple myeloma.

Authors:  Robert A Kyle; Morie A Gertz; Thomas E Witzig; John A Lust; Martha Q Lacy; Angela Dispenzieri; Rafael Fonseca; S Vincent Rajkumar; Janice R Offord; Dirk R Larson; Matthew E Plevak; Terry M Therneau; Philip R Greipp
Journal:  Mayo Clin Proc       Date:  2003-01       Impact factor: 7.616

8.  Multiple myeloma: causes and consequences of delay in diagnosis.

Authors:  C C Kariyawasan; D A Hughes; M M Jayatillake; A B Mehta
Journal:  QJM       Date:  2007-09-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.